|
IMF reports from the 2004 annual meeting of the American Society of Hematology in San Diego, California. In addition to special interviews with the researchers presenting at ASH, a special, CME-accredited program, Controversies in Myeloma Management, brought together leading experts to discuss clinical practice issues in the context of patient case studies.
|
|